deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT01358266

Study Assessing Double-masked Uveitis Treatment (SAKURA)

A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

Sponsor: Santen Inc.

Updated 12 times since 2017 Last updated: Jun 21, 2019 Started: May 31, 2011 Primary completion: Sep 30, 2016 Completion: Dec 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Uveitis; Posterior, Disorder, this trial is completed. The trial is conducted by Santen Inc. and has accumulated 12 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotCompleted~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotCompleted~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshotCompleted~Nov 2025 – present · 10 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Nov 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2025 — Nov 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE3

Show 7 earlier versions
  1. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

  2. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE3

  3. Aug 2019 — Jan 2021 [monthly]

    Completed PHASE3

  4. Jun 2018 — Aug 2019 [monthly]

    Completed PHASE3

  5. Oct 2017 — Jun 2018 [monthly]

    Completed PHASE3

  6. Feb 2017 — Oct 2017 [monthly]

    Completed PHASE3

  7. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Santen Inc.
Data source: Santen Inc.

For direct contact, visit the study record on ClinicalTrials.gov .